Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have
metastatic, recurrent, or locally advanced, ovarian cancer, breast cancer, or metastatic or
unresectable solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University